OKUR — OnKure Therapeutics, Inc. · P/E 72, rev $2.0M

OnKure Therapeutics, Inc. (OKUR) is a biotechnology company listed on US.

Latest reported OKUR revenue for 2026-06-30 was $2.0M. Net income was -$30.5M. OKUR currently screens at market cap $76.6M and trailing P/E 71.8.

Use this OKUR page for company research — sector, financials, and the latest filing takeaway — not a live tape. The session quote (last, range, volume) lives on the OKUR quote page. Cached 10-K, 10-Q, 8-K, and Form 4 exhibits are on the OKUR SEC filings page. Lician reads the product cache first so this HTML stays unique to OnKure Therapeutics, Inc. even when a live quote feed is slow.